"Protein Binding" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
| Descriptor ID |
D011485
|
| MeSH Number(s) |
G02.111.679 G03.808
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Protein Binding".
Below are MeSH descriptors whose meaning is more specific than "Protein Binding".
This graph shows the total number of publications written about "Protein Binding" by people in this website by year, and whether "Protein Binding" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2003 | 1 | 12 | 13 |
| 2004 | 0 | 13 | 13 |
| 2005 | 0 | 13 | 13 |
| 2006 | 0 | 21 | 21 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 10 | 10 |
| 2009 | 0 | 15 | 15 |
| 2010 | 0 | 17 | 17 |
| 2011 | 0 | 7 | 7 |
| 2012 | 0 | 6 | 6 |
| 2013 | 0 | 22 | 22 |
| 2014 | 0 | 19 | 19 |
| 2015 | 0 | 16 | 16 |
| 2016 | 0 | 30 | 30 |
| 2017 | 2 | 338 | 340 |
| 2018 | 2 | 258 | 260 |
| 2019 | 2 | 86 | 88 |
| 2020 | 3 | 132 | 135 |
| 2021 | 6 | 162 | 168 |
To return to the timeline, click here.
Below are the most recent publications written about "Protein Binding" by people in Profiles.
-
An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility. Bioengineered. 2021 12; 12(1):4407-4419.
-
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
-
DLpTCR: an ensemble deep learning framework for predicting immunogenic peptide recognized by T cell receptor. Brief Bioinform. 2021 11 05; 22(6).
-
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein. Blood. 2021 10 07; 138(14):1269-1277.
-
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy. 2022 01; 77(1):111-117.
-
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants. J Virol. 2021 09 09; 95(19):e0068521.
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect. Phytother Res. 2021 Oct; 35(10):5847-5860.
-
Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion. Elife. 2021 08 31; 10.
-
Mechanical activation of spike fosters SARS-CoV-2 viral infection. Cell Res. 2021 10; 31(10):1047-1060.